KEAP1 and cancer: By contrast, this study established the mouse model that recapitulates the clinical phenotypes of low-level immune cell infiltration into NRF2-activated tumors using syngeneic 3LL cancer cells harboring genetic manipulations in Keap1 and Nrf2 genes.